MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC

Dansin, Eric; Cinieri, Saverio; Garrido, Pilar; Griesinger, Frank; Isla, Dolores; Koehler, Manfred; Kohlhaeufl, Martin

dc.contributor.author	Kohlhäufl, Martin
dc.date.accessioned	2014-04-11T14:25:10Z
dc.date.available	2014-04-11T14:25:10Z
dc.date.issued	2012
dc.identifier.issn	0169-5002
dc.identifier.uri	http://hdl.handle.net/10900/51453
dc.language.iso	en	de_DE
dc.publisher	Elsevier Ireland Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.lungcan.2011.11.020	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	MO19390 (SAiL): Bleeding events in a phase IV study of first-line bevacizumab with chemotherapy in patients with advanced non-squamous NSCLC	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_02169	de_DE
utue.publikation.seiten	373-379	de_DE
utue.personen.roh	Dansin, Eric
utue.personen.roh	Cinieri, Saverio
utue.personen.roh	Garrido, Pilar
utue.personen.roh	Griesinger, Frank
utue.personen.roh	Isla, Dolores
utue.personen.roh	Koehler, Manfred
utue.personen.roh	Kohlhaeufl, Martin
dcterms.isPartOf.ZSTitelID	Lung Cancer	de_DE
dcterms.isPartOf.ZS-Issue	3	de_DE
dcterms.isPartOf.ZS-Volume	76	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE